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Abstract: Unprotected exposure of skin to solar ultraviolet radiation (UVR) may damage the DNA
of skin cells and can lead to skin cancer. Sunscreens are topical formulations used to protect skin
against UVR. The active ingredients of sunscreens are UV filters that absorb, scatter, and/or reflect
UVR. Preventing the formation of free radicals and repairing DNA damages, natural antioxidants are
also added to sunscreens as a second fold of protection against UVR. Antioxidants can help stabilise
these formulations during the manufacturing process and upon application on skin. However, UV
filters and antioxidants are both susceptible to degradation upon exposure to sunlight and oxygen.
Additionally, due to their poor water solubility, natural antioxidants are challenging to formulate and
exhibit limited penetration and bioavailability in the site of action (i.e., deeper skin layers). Cyclodextrins
(CDs) are cyclic oligosaccharides that are capable of forming inclusion complexes with poorly soluble
drugs, such as antioxidants. In this review, we discuss the use of CDs inclusion complexes to enhance
the aqueous solubility of antioxidants and chemical UV filters and provide a protective shield against
degradative factors. The role of CDs in providing a controlled drug release profile from sunscreens
is also discussed. Finally, incorporating CDs inclusion complexes into sunscreens has the potential to
increase their efficiency and hence improve their skin cancer prevention.
Keywords: natural antioxidants; UV filters; cyclodextrins; hydroxypropyl-β-cyclodextrin; inclusion
complex; sunscreens; quercetin; trans-resveratrol
1. Introduction
Ultraviolet radiation (UVR), mainly coming from the sun, is divided into three main
categories: UVA, UVB, and UVC. As UVA and UVB reach the Earth, they can be harmful
to living cells, causing various skin damage. Although UVA radiation has the least energy,
it can reach deep skin layers, leading to the generation of free radicals and consequently
long-term and indirect damage to DNA. Having higher energy, UVB radiation can cause
direct damage to DNA and subsequently lead to skin cancer [1,2]. On the other hand,
although UVC radiation has the highest energy, it is blocked by the atmospheric ozone
layer; hence, it does not have a harmful impact on skin [3].
Sunscreens adopt two approaches to provide UV protection: (a) prevention of free
radical generation (via UV filters) and (b) scavenging of free radicals (via antioxidants) [4].
UV filters act on the skin surface and tend to provide skin protection by absorbing, re-
flecting, and/or scattering destructive UV light [5]. However, even with the application
of sunscreens of high sun protection factor (SPF), the epidermis is still exposed to low
levels of UVR, leaning to the generation of UV-induced free radicals within the skin [6].
This explains the need to incorporate radical scavenging antioxidants into sunscreens’
formulations. Free radical neutralisation is achieved with a variety of antioxidants, often
Molecules 2021, 26, 1698. https://doi.org/10.3390/molecules26061698 https://www.mdpi.com/journal/molecules
Molecules 2021, 26, 1698 2 of 22
with a combination of both lipid- and water-soluble antioxidants to ensure complete pro-
tection. When added to cosmetic formulations, antioxidants interfere with the cascade of
UV-induced free radical reactions, thus protecting the skin from oxidative stress.
An ideal sun protection formulation should provide a broad protection through the
range of UVA to UVB (280–400 nm) radiation. It should also be designed to prevent UV
filters from penetrating the epidermis given their potential toxicity, whilst enabling antiox-
idants to penetrate the viable layers of the epidermis and exert their effects [7]. Finally,
the formulation should show good photo, chemical, and thermal stability. However, re-
search over the past couple of decades has indicated that a multitude of sunscreens do
not meet these requirements. In fact, UV filters, given their nature, can absorb UVR
and consequently undergo photo-addition, photo-fragmentation, and rearrangement reac-
tions [8]. These reactions often produce undesired free radical species, which can lead to
the degradation of other ingredients within the cream formulation. Similarly, the affinity
for antioxidants to free radical species translates to high susceptibility to oxidation and
subsequent degradation. For instance, α-tocopherol (vitamin E), one of the most effective
free-radical scavengers in modern skin care, exhibits poor UV stability and subsequently
low activity times [4,9,10]. Additionally, lipophilic antioxidants have a tendency to aggre-
gate, thus hindering their permeation of the skin and leading to poor bioavailability [11,12].
Finally, several UV filters have been detected in blood plasma following topical application.
A recent report form the Food and Drug Administration (FDA) showed that six sunscreens
UV filters were found to be present in blood plasma at concentrations that surpassed the
FDA’s threshold [13].
Cyclodextrins (CDs) are cyclic oligosaccharides with the shape of a hollow truncated
cone. CDs unique chemical structures allow them to entrap poorly soluble drugs, such
as antioxidants, leading to significant enhancement of drug solubility and stability [14].
Therefore, certain formulation-related measures, such as using a CDs inclusion complex,
could be undertaken to enhance antioxidants’ bioavailability and maintain the stability,
efficiency, and safety of both antioxidants and UV filters throughout the sunscreen’s
lifecycle and post application.
In this review, the impact of UVR radiation on skin is firstly introduced. Subsequently,
sunscreens, UV filters, and natural antioxidants are reviewed considering the potential use
of CDs to improve their solubility, stability, and biological efficiency. Finally, the inclusion
complexes of UV filters and natural antioxidants with different CDs are critically assessed
for their potential to enhance sunscreen’s therapeutic effect in preventing UVR-induced
skin cancers.
2. Skin Structure and UV Radiation
Skin primarily consists of three layers: epidermis, dermis, and subcutaneous. The
epidermis (50–100 µm) consists of non-viable epidermis and viable epidermis. Non-viable
epidermis (10–15 µm), also known as the stratum corneum, is the uppermost skin layer
that provides the primary barrier against the drugs permeation [15]. The viable portion of
the epidermis (≈70 µm) is further subdivided into four layers; stratum lucidum (viable
uppermost layer), stratum granulosum, stratum spinosum, and stratum basale [16]. The
stratum basale is the closest layer to the dermis and contains various cell structures. These
include keratinocytes, which produce the protective protein keratin, melanocytes, which
synthesise melanin, Langerhans cells, where the main antigen-presenting cells (APC) are
located, and Merkel cells that contain sensory neurons and stimulate sensations of touch
and pain [17]. The majority of skin melanomas are present in the epidermis and can be
divided into two main types: non-malignant melanoma and malignant melanoma. The
most common non-melanoma skin cancers are basal cell carcinoma (BCC) (accounting for
approximatly 75% of non-melanoma skin cancers) and squamous cell carcinoma (SCC),
which in both cases affect the epidermal keratinocytes [18]. The dermis layer (3–5 mm) is
the major constituent of the skin. The dermis is metabolically active and represents the
main site of wound repairing. Therefore, it is essential for most drugs to reach this layer
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to exert therapeutic effects. Furthermore, the dermis contains various enzymes such as
esterases, peptidases, and hydrolases, increasing the metabolic activity of the skin and
reducing the skin bioavailability of drugs [19,20]. The subcutaneous tissue, known as the
hypodermis, is the innermost skin layer that accommodates blood vessels and connective
tissues [15].
UVR can be divided into three main spectrums: UVA (315–400 nm), UVB (280–315 nm),
and UVC (200–280 nm) [3,21]. While the majority of UVR reaching the Earth is within the
UVA spectrum, 5 to 10% comes from UVB. On the other hand, UVC is entirely blocked by
the ozone layer; hence, it does not affect the biota. The radiation energy is inversely propor-
tional to the wavelength; the longer the wavelength, the lower the energy. Conversely, the
skin penetration depth is proportional to the wavelength. Therefore, UVA can penetrate
deep layers of the epidermis, reaching the basal layer while UVB can only penetrate the
epidermis, given its shorter wavelength.
Figure 1 shows a cross-sectional view of human skin along with the UVR wavelength-
dependent penetration.
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Upon sun exposure, the epidermal APCs are affected by the UVR immunosuppres-
sion. As a result, the number of these cells decreases, whereas the number of inflammatory
cells increases. This contributes to the development of various diseases including skin
cancer [22]. As UVA reaches the deep skin layers, it reacts with the skins endogenous pho-
tosensitisers. Once activated, photosensitisers initiate photosensitising reactions leading to
the generation of reactive oxygen species (ROS) [23,24]. ROS are highly reactive species
that induce oxidative cellular stress and alteration in cellular functionality. This leads to an
indirect damage of DNA nd conseque tly skin diseases, including skin cancer [25]. On the
other hand, as UVB can only penetrate the no -vi ble upper layers of skin, it was thought
that it d es no affect DNA molecules, but it may only ca se lighter skin damages such as
suntan and sunburn [1]. However, later studies showed that due to its high energy, UVB
can still cause mole ular rearrangements nd lead to DNA d mag and cell cycle changes.
Once the damage is done, mutations occur, a d with their ac umulation, genetic and molec-
ular int grity of the DNA are disrupted, resulting in the fi st stages of skin cancer [23]. UVB
can also activate cyclooxygenase-2 (COX-2) enzyme, increasing prostaglandins production
and promoting inflammation [26]. Finally, both UVA and UVB were also found to stimulate
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the generation of superoxide anion radicals via the activation of the enzyme nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase and respiratory chain reactions [2].
The highest rates of skin cancer incidence in the globe are seen in Australia, where
around 1% of the population develop BCC. Moreover, incidences of BCC and SCC in
Australia are almost three times higher in populations closer to the equator with greater
UVR [27]. It is well accepted that the risk of skin cancer is strongly correlated to UV
exposure as a child/adolescent as well as prolonged exposure as an adult [28,29]. Malignant
melanoma poses the greatest risk to human health of all the skin cancers [30]. As the fifth
most common cancer in the UK, malignant melanoma accounts for around 80% of deaths
by skin cancer [31]. Overexposure to solar UVR has been found as the cause of 86% of all
melanoma cases.
3. Sunscreens
To prevent UVR skin damage, sunscreens were developed and introduced to the phar-
maceutical and cosmetic market. Sunscreens are topical preparations, usually emulsions
made of a two-phase system: oil in water (O/W) or water in oil (W/O). UV filters are the
main active ingredient in sunscreen formulations [5].
3.1. UV Filters
Based on their mode of action, UV filters can be classified as (1) physical (inorganic) fil-
ters that reflect and scatter the light and (2) chemical UV filters that absorb the UVR (mainly
UVB). The efficiency of UV filters is given by SPF value, indicating their ability to protect
the skin against UVR; the higher the SPF, the better the sunburn protection [32]. While the
maximum authorised concentrations of chemical UV filters in sunscreen formulations are
usually reported at a range of 5–15% w/w of the formulation, physical UV filters could be
added at higher concentrations (up to 25% w/w) [33,34]. Table 1 summarises some of the
commonly reported physical and chemical UV filters used in sunscreen formulations.
Table 1. Examples of UV filters used in sunscreen formulations [33,35,36].
Chemical UV Filters Physical UV Filters
Benzophenones (UVA)
Oxybenzone (UVA and UVB)













To remain effective and pharmacologically inert, UV filters must only reside on the
stratum corneum surface. The permeation of UV filters across skin not only compromises
their photoprotection capacity but can also lead to severe toxic and allergic reactions [7].
Due to low permeability through skin layers, the potential for physical UV filters to
cause hypersensitivity reactions is reduced [25]. However, physical UV filters tend to
leave a white opaque layer on the skin surface, which is attributed to their scattering
properties [2]. Therefore, the use of chemical filters is more commercially appealing [37].
To increase photoprotection, sunscreen formulations usually contain both chemical and
physical UV filters. However, the combination could lead to photocatalytic and photolytic
reactions, leading to the deterioration of their structure and efficacy [38]. The particle size
of physical UV filters can affect the photostability of chemical UV filters. For example,
the photodegradation of avobenzone was 12% higher when nanosized titanium dioxide
particles (<25 nm) were used instead of micro-sized titanium dioxide (~0.6 µm). This was
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explained by the increased surface area that nanoparticles have, and therefore the greater
amount of photocatalytically generated ROS [38].
3.2. Antioxidants
Antioxidants are a crucial group of compounds that protect the body from excessive
free radical oxidation. Antioxidants can be categorised either as primary, secondary, or
tertiary antioxidants or as enzymes, vitamins, flavanoids, carotenoids, phenolic acids, and
polyphenols (Figure 2) [39]. Primary (or preventative) antioxidants work via the inbihibtion
of radical initiation reactions to slow the rate of radical production. Secondary antioxidants,
otherwise known as chain-breaking antioxidants, work by disrupting the propagation
reactions, and tertiary antioxidants work by repairing the damage caused by free radical
oxidation [40].
Figure 2. Classifications of antioxidants.
Antioxidants are added to sunscreen formulations to provide a second layer of defence,
as UV filters alone cannot block 100% of UVR from reaching the skin (a product with SPF
50+ filters 98.3% of UVR). Unlike UV filters, antioxidants must penetrate deeper skin
layers to reach their site of action. When applied to the skin, antioxidants’ main benefit
resides in their ability to scavenge UV-induced ROS and free radicals, hence reducing
DNA damage, skin ageing, and diseases [41,42]. There are many different mechanisms
of action of antioxidants; two common examples of such are hydrogen atom transfer
(HAT) and single electron transfer (SET) reactions. A single antioxidant can often work
via more than one mechanism, depending on the site of action, the pH, and the radical
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being scavenged [28]. The influencing parameter in HAT reactions is the bond dissociation
energy of the hydrogen-donating group of the antioxidant [29]. However, for SET reactions,
it is the ionisation potential of the antioxidant that dictates its potency [27]. For this reason,
some antioxidants are more suited to HAT than SET reactions and vice versa. Sunscreens
often incorporate a selection of antioxidants with different radical scavenging properties to
increase the formulation’s protection. Each antioxidant molecule reacts with one active free
radical, transforming it into a non-radical species. This cycle continues until the ROS chain
reaction is terminated [43]. Figure 3 shows the radical scavenging mechanism of quercetin
(QCT), a flavanoid antioxidant, on the superoxide anion radical, O2−.
Figure 3. The radical scavenging mechanism of the superoxide anion by quercetin [44].
Although combining antioxidants with UV filters has a synergistic effect on the overall
SPF value, it was reported that the antioxidant’s efficiency (i.e., radical protection factor)
can be reduced upon the incorporation UV filters. Nonetheless, the SPF gained by this
combination is still worth such a compromise [33]. Furthermore, antioxidants can help
improve sunscreen formulation’s photostability and thus enhance their efficiency and
safety [7]. In fact, the absorption of UV photons by a chemical UV filter, e.g., avobenzone,
can lead to the formation of singlet oxygen free radicals, resulting in post-application
degradation of the sunscreen product itself. Alfonso et al. reported that a combination
of three antioxidants (ubiquinone, vitamins C, and E) stabilised UV filters, reduced the
production of reactive species, and consequently increased the overall extent and duration
of photoprotection [45].
Preferred by consumers, natural antioxidants stabilise sunscreen formulations and
promote biocompatibility with reduced toxicity. Furthermore, natural antioxidants are
more readily available and produce sunscreen products at a relatively low price compared
to synthetic antioxidants [3]. Some commonly used natural antioxidants with their chemical
structures are shown in Figure 4.
Flavonoids, such as QCT and rutin, are natural antioxidants that are frequently used
in sunscreen formulations. These phenolic compounds have UV absorbing and anticancer
properties [46,47]. As a result of the ROS scavenging capacity, QCT can prevent UVR-induced
skin damage and inhibit the growth of tumour cells. Additionally, QCT has anti-inflammatory
properties attributed to its capacity to inhibit the production of several inflammatory mediators
such as the COX-2 enzyme [48]. Furthermore, it was reported that QCT can enhance the
photostability of both UVA and UVB filters by inhibiting the activity of tyrosinase enzyme,
hence decreasing photolabile activities on the skin [49].
Rutin is a non-toxic, non-oxidisable QCT derivative. Its chemical structure, includ-
ing phenolic rings and free hydroxyl groups, gives it the ability to form intramolecular
hydrogen bonds with free radicals (i.e., good antioxidant activity). Taira et al. analysed the
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scavenging abilities of rutin (extracted from Mallotus japonicus). It was found that rutin
was able to inhibit tyrosinase activity and reduce the melanin content of murine melanoma
cell lines by approximately 40% [49]. The extract showed no cytotoxicity, suggesting that it
is safe for use in cosmetic and cosmeceutical preparations. Moreover, Corina et al. demon-
strated that the antiproliferative activity of rutin was directly related to higher cellular
uptake, leading to an increased apoptotic activity against cancer cells [50].
Figure 4. Chemical structures of commonly natural antioxidants complexed with cyclodextrins (CDs):
(A) quercetin (QCT), (B) rutin, (C) ferulic acid, (D) trans- resveratrol, and (E) epigallocatechin Gallate.
Ferulic acid (FA) is a phenolic compound with high antioxidant and radical scaveng-
ing activities. FA is also known for its anti-inflammatory effect due to its antiproliferative
properties and the inhibition of the COX-2 enzyme [51]. Furthermore, FA helps to preserve
the physiological cell integrity when exposed to air and UVR, thus preventing the forma-
tion of cancerous cells. Interestingly, FA also demonstrates UV-absorbing characteristics,
promoting its use in sunscreen products [52].
Resveratrol (RES) is another phenolic compound known for its antioxidant and anti-
cancer properties. RES can modulate the metabolism of lipids by protecting lipoproteins
against damages induced by free radicals [53]. The trans-RES isomer has superior antioxi-
dant, anti-inflammatory, and antitumoral properties [7]. It was found that trans-RES can
inhibit lipid peroxidation more intensively than vitamin E or C [54]. This triple effect helps
protect skin, fight diseases, and reduce edema, inflammation, and UVB-induced sunburn.
Additionally, the anti-inflammatory properties of RES are correlated to its ability to inhibit
photo-carcinogenesis.
Green tea polyphenols (GTP) are also used in topical applications, including sun-
screens, for their antioxidant activity [55]. It was found that epigallocatechin gallate
(EGCG), the main phenolic compound found in GTP, inhibited the synthesis of the COX-2
enzyme. This reduces the expression of hydrogen peroxide and consequently resists the
generation of gene mutations and reduces the infiltration of leukocytes, which is a major
source of ROS production [26].
The immense therapeutic potential of natural antioxidants is limited by their poor sol-
ubility and their formation of aggregates in water [56]. This results in poor bioavailability
and low binding affinities to target receptors. Furthermore, natural antioxidants are also
susceptible to degradation once exposed to oxidative factors such as light, heat, air, mois-
ture, and UVR [11,12]. This explains the high doses of antioxidants in sunscreens in order
to achieve the intended therapeutic effects. Therefore, the protection of antioxidants via
formulation-related approaches is encouraged to enhance their stability and bioavailability.
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The use of CD inclusion complexes in sunscreens is an emerging method for improving
the incorporation of UV filters and antioxidants into formulations. Their ability to improve
the solubility of lipophilic antioxidants and protect UV filters from photodegradation
make it an appealing option. Solubility issues tend to be more prevalent with lipophilic
antioxidants such as flavanoids, polyphenols, and carotenoids. For this reason, antioxidant–
CD inclusion complexes with these categories of antioxidants offer greater potential value
to the sunscreen industry than those complexes with already water-soluble antioxidants
such as vitamin C and uric acid.
4. Cyclodextrins (CDs)
4.1. General Concept
CDs are cyclic oligosaccharides produced by the enzymatic degradation of starch,
where the formed glucose residues link together by glycosidic bonds and form a macro-
cycle. Depending on the number of α-glucose units, CDs can be divided into three main
types: α-CD, β-CD, and γ-CD, consisting of 6, 7, and 8 glucopyranose units linked by
1–4 bonds, respectively (Figure 5) [57,58]. CDs have a truncated-cone-shaped structure
with hydrophilic surfaces and hydrophobic cavities. This unique structure allows them to
entrap poorly soluble drug moieties, such as natural antioxidants and anticancer drugs,
in their hydrophobic cavities to form inclusion complexes [59]. Several factors contribute
to an effective formation of an inclusion complex. The guest molecule is efficiently main-
tained inside the cavity by noncovalent forces including hydrogen bonds, hydrophobic
interactions, and van der Waals forces. The number of CDs glucose units determines the
diameter and volume of its cavity (Figure 5) [60]. With eight glucose units, γ-CD have
the largest cavity size, making it capable of accommodating relatively large antioxidants.
However, larger cavities do not necessarily mean higher inclusion complex stability, as
large cavities might allow an easy escape of guest molecules [61]. β-CD is the most used
form in pharmacy, as its cavity size is the best fit for most drugs with molecular weight
ranging between 200 and 800 Daltons [12]. However, due to its high lattice energy, which is
attributed to the crystalline structure and intramolecular hydrogen bonding, β-CD solubil-
ity in water is relatively low [62]. Therefore, its chemical structure was modified to result
in more amorphous, soluble, and potentially safer form of CDs [62,63]. For instance, the
hydroxypropylated form (HP-β-CD) has higher solubility, reduced toxicity, and enhanced
complexability compared with β-CD [64,65].
Different methods are used to prepare drug–CDs inclusion complexes, including
co-precipitation, freeze drying, ball milling, and kneading [66,67]. The preparation method
could affect the characteristics of the resulting inclusion complex [68]. Both freeze drying
and co-precipitation methods yield higher entrapment efficiency; however, the freeze-
drying method is costly and time consuming. In contrast, the kneading technique shows
lower efficiency in entrapment capabilities [12]. Therefore, the co-precipitation method is
more commonly used in preparing a stable inclusion complex of antioxidants [69].
CDs can act as a shield that protects the encapsulated molecules of antioxidants and
UV filters, promoting their stability against external stimulus and oxidative stress [51,70].
The chemical stability of CDs is mainly attributed to the absence of reducing glycosidic units
from their structures. The adjacent C-2 and C-3 hydroxyl groups of the glucopyranose units
form hydrogen bonds that contribute further to the chemical stability of CDs’ structures
and help promote solubility in water [57]. Furthermore, CDs are known to resist enzymatic
hydrolysis due to burying all bridge oxygens inside the nonpolar ring center [71]. These
bridges bind to the encapsulated antioxidants or UV filters, making them less available
to interact with extracellular molecules [62]. Furthermore, due to the hydrophilic nature
of their outer surface, CD-antioxidant inclusion complexes display enhanced solubility,
hence enhanced bioavailability, and they can also be employed to modify the release of
antioxidants from topically applied sunscreens [70]. Interestingly, following the application
of CD-containing sunscreens, the CDs themselves can act as a protective film and UV filter
adjuvant that absorbs UVR [72,73].
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Figure 5. Types of cyclodextrins; α-CD (n = 6), β-CD (n = 7), and γ-CD (n = 8) with their geometric
dimensions (bottom) [57].
4.2. UV Filters/CDs Inclusion Complex
CDs have been assessed for the protection of UV filters against photodegradation and
oxidation and for their ability to restrict UV filters permeation into deep skin layers [74,75].
For example, β-CD was found to photostabilise different UV filters (oxybenzone, octocrylene,
and ethylhexyl-methoxycinnamate). A significant photostability enhancement of UV filters
was observed when β-CD was used compared to that in the absence of β-CD. It was found
that in a cream sample containing no β-CD, there was a drop in the absorbance of λmax = 287
and 309 nm, from ≈3.75 to ≈1.75 following 3 h of UV irradiation. However, with the inclusion
of 5 g of β-CD, this drop in absorbance was dramatically reduced, and with 10 g of β-CD, the
absorption profile remained almost constant after 3 h (Figure 6) [76].
Figure 6. Change in UV absorption spectra of sunscreen sample containing a mixture of UV filters after different times of
irradiation. (a) Free of β-CD; (b) 5 g β-CD; (c) 10 g β-CD [76].
4-Methylbenzylidene camphor (4-MBC, also known as enzacamene) is considered a
relatively photostable organic UVB filter. However, a recent study showed that 4-MBC
may decompose upon exposure to direct sunlight [77]. Scalia et al. reported that among
different types of CDs, random methyl-β-CD (RM-β-CD) was found to have an optimal
solubilising and photostabilising effect for 4-MBC. This was mainly attributed to CD’s
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ability to form a protective shield around 4-MBC and thus decrease the level of direct
interaction with UVR [78].
Chemical UV filters tend to penetrate the skin after topical application. This not
only decreases their photoprotective capabilities but also leads to phototoxicity or photo-
allergenicity. According to Scalia et al., the amount of avobenzone penetrating the stratum
corneum was significantly reduced after encapsulation in HP-β-CD, with >70% of the
applied dose remaining on the uppermost skin layer [79]. Furthermore, the permeation
of UV filters was dependent on CDs concentrations; higher concentrations of HP-β-CD
resulted in lower flux rates [80]. Likewise, the inclusion complex of oxybenzone in HP-
β-CD and sulfobutylether-β-CD (SBE-β-CD) led to an increase in the aqueous solubility
of oxybenzone (up to 1049-fold) whilst significantly limiting its percutaneous absorption
(Figure 7) [81]. Furthermore, Shokri et al. reported that the absorption lag time and overall
percutaneous flux of avobenzone, oxybenzone, and ensulizole were reduced by 4 to 15-fold
after complexation with β-CD [82].
Figure 7. Penetration of oxybenzone across human epidermis to the receptor phase from solutions
containing free or complexed sunscreen agent [81].
Due to its relatively low price and its absorption of both UVA and UVB radiation,
UV filter benzophenone-3 is regularly used in sunscreen formulations. Its maximum
permissible concentration in formulations is 6%, and its transdermal absorption can reach
2% after topical application [83]. A benzophenone-3–HP-β-CD complex was shown to
enhance benzophenone-3 solubility and photostability and decrease its penetration through
cell membranes. The permeability rates of benzophenone-3 were evaluated in vivo, and
the benzophenone-3-HP-β-CD complex was found to have permeated less through the
skin of healthy volunteers than the free form of benzophenone-3 [83].
The effect of employing CD-UV filters inclusion complexes on the overall SPF value
of the formulation was investigated. While some studies reported negligible to minor
increases in the formulation SPF when CD-UV filters inclusion complexes were used [84,85],
other reported more significant effects. For instance, Srinivasan et al. measured the SPF
values of two commercial sunscreens with and without β-CD complexes of different
dinitro compounds (dinitrophenol, dinitroaniline, and dinitrobenzoic acid). The results
showed that with the β-CD inclusion complexes, the SPF was increased by up to 19.6% [86].
Similarly, Felton et al. analysed the photoprotective effects of the HP-β-CD-oxybenzone
inclusion complex. It was reported that a 5% HP-β-CD inclusion complex formulation
provided sun protection equivalent to SPF 30 commercial sunscreen [87].
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4.3. Natural Antioxidant/CDs Inclusion Complex
CDs provide antioxidant protection and enhance their solubility, stability, and hence
their bioavailability and biological activity. Consequently, lower doses of antioxidants
can be used, allowing better therapeutic index with reduced cost [11,37,88]. CDs are
capable of entrapping large amounts of antioxidants. For instance, the loading capacity
studies estimated an 80% inclusion of RES in the methyl-β-CD cavity [89]. Several factors
contribute to a successful and strong formation of an antioxidant–CDs inclusion complex.
These include the type of solvent used in the inclusion complex preparation, the pH,
temperature, and mixing time. According to D’Aria et al., the optimised conditions that
yielded the best solubility enhancement of the QCT–CDs inclusion complex were pH = 8.0
at 37 ◦C with a mixing time of 72 h [90]. In addition to temperature and reaction time,
the mixing speed is also influential on the entrapment efficiency of antioxidants in CDs’
cavities [65]. Zhu et al. evaluated the influence of the mixing time, temperature, and
molar ratio on the inclusion of chrysin (5,7-dihydroxyflavone) within the β-CD cavity.
Temperature was reported to have the greatest effect on the inclusion rate, followed by the
molar ratio and mixing time [91]. Table 2 summarises the main outcome of antioxidant–CDs
complexation studies reviewed in this work.
Table 2. Summary of outcomes of antioxidant–CD inclusion complexes in reviewed studies.
Antioxidants CDs Inclusion Complex Preparation Method, Stoichiometry, andMain Outcome Reference
Rutin β-CD, HP–α-CD,HP–β-CD, HP–γ-CD
Inclusion complex prepared by mixing in solution with (1:1)
stoichiometry with greater stability obtained using HP-β-CD and
HP-γ-CD. Moderate protection of rutin against thermal and UVR
degradation and significant enhancement of antioxidant capacity.
[56]
Astaxanthin HP–β-CD
Inclusion complex obtained by freeze drying. Significant
enhancement in antioxidant stability against light and oxygen,
allowing controlled release.
[92]
Coenzyme Q10 β-CD, γ-CD
Inclusion complex prepared by co-precipitation method with (1:1)
stoichiometry. Significant enhancement in antioxidant solubility
and thermo- and photostability.
[93]
C60(OH)10 HP–β-CD
Inclusion complex/nanoparticles obtained by dry grinding using
automated magnetic mortar. Significant enhancement in
antioxidant scavenging ability, allowing better cell protection
against oxidative stress. The IV administration of nanoparticles
suppressed liver injury induced by oxidative stress.
[94]
Vitamin E HP–β-CD
Inclusion complex prepared by mixing and electrospinning.
Enhancement of vitamin E solubility, antioxidant activity, and
light and shelf stability.
[43]
Phloretin Me–β-CD, HP–β-CD
Inclusion complex prepared by freeze drying with (1:1)




Inclusion complex prepared by co-precipitation with compressed
antisolvents method. In vitro and in vivo enhancement in
Baicalein solubility, antioxidant activities, and bioavailability.
[69]
Lycopene β-CD
Inclusion complex obtained by co-precipitation with (1:1)





Inclusion complex obtained by the freeze-drying method.
Enhancement of water solubility allowing anticancer effects
against cutaneous SCC cells.
[95]
Resveratrol HP–β-CD
Inclusion complex obtained by mixing and electrospinning in the
presence of polyvinylpyrrolidone. Resveratrol converted to
amorphous form with intermolecular bonds with PVP and
HP-β-CD. Good antioxidant activity and skin penetration and
suppressed particulate matter-induced expression of
inflammatory proteins.
[96]
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Table 2. Cont.
Antioxidants CDs Inclusion Complex Preparation Method, Stoichiometry, andMain Outcome Reference
Ferulic Acid α-CD, β-CD, γ-CD,HP–β-CD, HP–γ-CD
Inclusion complex obtained by co-precipitation with (1:1)
stoichiometry. α-CD was best in term of association constant,
degree of photostability, and FA release.
[97]
QCT Me–β-CD
Inclusion complex obtained by freeze drying. Enhanced QCT
solubility and photostability, without significantly affecting the




Inclusion complex prepared by saturated aqueous solution
method with (1:1) stoichiometry. Water solubility increased by 70
to 102 times with improved antioxidant activity.
[98]
Rutin β-CD, HP–β-CD
Inclusion complex obtained by co-precipitation with (1:1)
stoichiometry. Enhanced antioxidant activity, solubility, and
photostability.
[99]
Curcumin β-CD crosslinked polymer
Inclusion complex obtained by pressure distillation and oven
drying resulting in (1:1) stoichiometry. Improved
physicochemical characteristics, novel AO activity, with higher
antiproliferative activity on A375 cell, and A375 cell apoptosis.
[100]
Ferulic Acid γ-CD
Inclusion complex obtained by co-precipitation. Good
encapsulation/release of ferulic acid for pharmaceutical
application and biological activity.
[101]
Ferulic Acid α-CD
Inclusion complex obtained by co-precipitation with (1:1)
stoichiometry. Slower release, with improved photostability and
bioavailability.
[51]
Ferulic Acid HP–β-CD Inclusion complex obtained by freeze drying and improved watersolubility and bioactivity. [64]
Chrysin β-CD (1:1) stoichiometry. The inclusion complex formed via A-ring ofchrysin. Increased solubility and antioxidant potential. [102]
Epigallocatechin
Gallate γ-CD (1:1) stoichiometry. Slight enhancement in antioxidant activity. [61]
Different
flavanols HP–β-CD
Increased antioxidant activity was attributed to CD capacity of
protecting flavanols against rapid oxidation by free radicals. [60]
Vitamin E HP–β-CD EN–HP–β-CD
Inclusion complex prepared by mixing in solution with
stoichiometry of (1:1). EN-HP-β-CD improved vitamin E
solubility by 25 times. Higher release in pH 4.5 (pH-sensitive
properties).
[103]
Ferulic acid 012 γ-CD
Inclusion complex obtained by co-grinding using a
three-dimensional ball mill with a stoichiometry of (1:1).
Five-fold enhancement in solubility.
[52]
Rutin β-CDHP–β-CD
Inclusion complex obtained by co-kneading method. Improved
antioxidant activity with antiproliferative and pro-apoptotic
activities against B164A5 cells.
[50]
Rutin β-CD
Inclusion complex obtained by co-grinding method with (1:1)
stoichiometry. Greater stability and solubility, but antibacterial
effect was slightly decreased. Prolonged released was observed
with twice as much rutin skin permeation.
[104]
QCT β-CD, HP–β-CD, SBE–β-CD
(1:1) stoichiometry. Inclusion ability of investigated CDs was in
the following order: SBE-βCD > HP-βCD > βCD. All obtained
complexes showed enhanced scavenging capability.
[17]
Phloretin HP–β-CD
Inclusion complex prepared by simple co-evaporation method
with (1:1) stoichiometry. The aromatic ring of phloretin was
included into the HP-β-CD cavity from the narrow side.




Inclusion complex obtained by mixing in solution with (1:3)
stoichiometry and inclusion rate of 90%. Increased solubility,
antioxidant, antimicrobial, and antitumour activities.
[91]
Resveratrol Me–β-CD (1:1) stoichiometry. Enhanced solubility (400-fold) and goodantibacterial and antioxidant activities with no haemolytic effect. [89]
Garlic Oil β-CD Inclusion complex obtained by co-precipitation with (1:1)stoichiometry. Improved solubility with controlled release profile. [105]
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4.3.1. Antioxidant Solubility Enhancement
The phase solubility analysis is a useful method that is usually used to evaluate
antioxidant–CDs solubility [100,106]. By plotting the molar concentration of solubilised
antioxidant versus the molar concentration of CDs, the stability constant (Kc) can be
determined using the intrinsic solubility (S0) and the slope of obtained diagram according





Figure 8. Phase solubility graph of QCT with HP-β-CD in phosphate (pH = 8.0) and citrate (pH = 3.6)
buffers [90].
It is often assumed that a linear solubility diagram indicates a 1:1 stichometry. How-
ever, this method may not be sufficient to calculate the antioxidant to CDs stoichiometry
or to confirm the presence of such a complex [107]. CDs and CD complexes tend to form
aggregates that may be able to solubilise drugs via non-inclusion complexes. Furthermore,
the fact that the Kc value determined by Equation (1) is dependent on the S0 value, which
is usually inaccurately measured for poorly soluble compounds, makes this method less
reliable. Therefore, Loftsson et al. introduced the complexation efficiency (CE) notion to
determine the solubility of the guest drug as per Equation (2):





(1 − slope) (2)
where CE is calculated using the slope of the phase-solubility diagrams independently of
both the intrinsic solubility of the drug, S0, and the intercept [108]. The stability constant
and the stoichiometry of the formed complex can also be determined using other analytical
techniques such electrospray ionisation mass spectroscopy [109] and nuclear magnetic
resonance (NMR) [51].
Carlotti et al. reported that the inclusion complex of QCT in α- and β-CD helped
improve its solubility and reduced photochemical reactivity [41]. Moreover, the water
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solubility of different flavonoids was enhanced by up to 100-fold after complexation with
propanediamine-β-cyclodextrin (DP-β-CD) [98]. Similar solubility enhancement of RES
was reported after complexation with HP-β-CD and RM-β-CD [68]. Furthermore, Me-β-
CD, a modified version of β-CD, forms a more robust inclusion complex [110], allowing a
400 times enhancement in RES’s solubility [89].
Several studies proved that HP-β-CD enhanced the solubility of entrapped drug
molecules significantly; however, its antioxidant entrapment efficiency is poor. Ethylenedi-
amine (EN) derivative of HP-β-CD enhances its properties and further increases antioxidant
entrapment and solubility [103]. For instance, while unmodified HP-β-CD was only able to
entrap 17.72% of vitamin E, the entrapment efficiency increased to 51% using EN-HP-β-CD.
This was mainly attributed to the crosslinked and porous structure of EN-HP-β-CD that
was able to create stronger interactions with loaded vitamin E; hence, it enhanced further
antioxidant solubility [103]. To produce the EN-HP-β-CD, HP-β-CD is oxidised using
sodium periodate and crosslinked with ethylenediamine (EN) to form C=N bonds. In
acidic conditions (e.g., the stratum corneum), C=N can be easily broken down, resulting in
a pH-sensitive controlled release of entrapped drug as shown in Figure 9 [103].
Figure 9. Cumulative release (%) of vitamin E, and its inclusion complexes with HP–β-CD and EN–HP–β-CD at pH 4.5.
and pH 7.0 [103]. EN: ethylenediamine, HP: hydroxypropylated form.
4.3.2. Antioxidant Stability Enhancement
CDs act as a shield that photo- and chemo-stabilises encapsulated antioxidants and
protects them from enzymatic oxidation [41]. The photostability of rutin, rutin–β-CD, and
rutin–HP–β-CD inclusion complexes was studied upon exposure to UVB irradiation. After
2 h of irradiation, the photodegradation percentages of rutin, rutin–β-CD, and rutin–HP–
β-CD were 13.6%, 5.44%, and 2.52%, respectively, reflecting a significant improvement
in rutin photostability after complexation with CDs [99]. Wang et al. evaluated the
photostability of the FA–HP–β-CD inclusion complex. While free FA underwent 10%
photodegradation in one hour of irradiation, it took more than eight hours of irradiation to
reach 10% degradation after FA was complexed with HP–β-CD (i.e., the free form of FA
experienced eight times faster degradation) [63]. Another successful example for using CD
as a protection shield against UVB is RES–HP–β-CD inclusion complexes. Approximately
80–90% of trans-RES is converted to its less active isomer (cis-RES) after one hour of light
exposure [111]. To overcome this limitation, Oliva et al. prepared RES–β-CD and RES–
RM–β-CD inclusions complexes and reported a significant increase in RES solubility and
photo and chemical stability after complexation [107]. In another study, RES–β-CD and
RES–HP–β-CD inclusion complexes were prepared, and their potential to inhibit human
cancer growth was investigated. While free RES had little inhibition on the viability of
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HeLa cells, both RES–β-CD and RES–HP–β-CD complexes exhibited high cytotoxicity
on two human cancer cell lines (HeLa, Hep3B) with no significant effect on normal cells.
Furthermore, the RES–HP–β-CD complex showed higher cytotoxicity than that of RES–β-
CD [53]. Similarly, FA also undergoes structural transformation to its less active cis-isomer
after UV irradiation. According to Monti et al., this phenomenon was not observed when
FA was protected inside the α-CD cavity, indicating the resulting inclusion complex’s
ability to provide a more stable active molecule [112].
4.3.3. Antioxidants Activity Enhancement
The enhanced solubility and stability of antioxidants after complexation with CDs lead
to enhanced antioxidant activity and biological efficiency. For instance, Zhu et al. reported
that while the scavenging ability of pure chrysin was dramatically weakened after UV
irradiation, that of the chrysin–β-CD complex was quite stable [91]. Similarly, the enhanced
stability of the rutin–β-CD complex against degradative factors resulted in enhancing its
scavenging capacity and bioavailability [99,104]. Hu et al. studied the antioxidant and
anticancer effects (using the HSC-1 cell line) of saikosaponin-d (SSD), before and after
complexation with HP–β-CD. It was found that 2.5 µM of SSD–HP–β-CD at a 1:5 molar
ratio provided optimum cytotoxic effects, which were not seen using the pure form of SSD
(Figure 10). This was attributed to the enhanced solubility of the SSD–HP–β-CD complex,
which was reflected in its bioavailability and anti-cancer activities [95].
Figure 10. Effects of 2.5 µM pure saikosaponin-d (SSD) and SSD–HP–β-CD on HSC-1 cell apoptosis
at 6 and 12 h [95].
4.3.4. Characterisation and Assessment
Different analytical techniques can be used to characterise antioxidant–CDs inclusion
complexes. This includes differential scanning calorimetry (DSC), thermogravimetric
analysis (TGA), infrared (IR) spectroscopy, nuclear magnetic resonance (NMR), X-ray
diffraction (XRD), and UV stability.
Thermodynamic analysis is used to confirm the inclusion of antioxidants in CDs
cavity and to evaluate the impact of temperature on antioxidants’ stability [113]. The
differential scanning calorimetry (DSC) curve of CDs usually displays a broadened en-
dothermic peak at 90–130 ◦C, which represents dehydration, followed by a decomposition
endothermic peak at around 300 ◦C. On the other hand, the guest molecule DSC curve is
often characterised by a well-defined sharp endothermic peak, indicating its melting point
and hence its crystalline nature. Thermogravimetric analysis (TGA) on the other hand
determines the weight of the sample with respect to change in temperature. Weight losses
are usually observed at around 100 ◦C corresponding to CD dehydration and above 300 ◦C
corresponding to the decomposition of the macrocycles. Any changes observed to the DSC
and TGA curve after complexation, such as broadening, disappearing, or shifting peaks
could indicate the loss of the crystallinity of the drug and the formation of an amorphous
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inclusion complex. Fir et al. used DSC and TGA thermograms (melting point positions,
dehydration extent, and thermal decomposition) to confirm the formation of coenzyme
Q10–CDs inclusion complexes and to assess their thermostability [93]. While uncomplexed
coenzyme Q10 and CDs physical mixtures were stable up to 250 ◦C, coenzyme Q10–CDs
inclusion complexes were stable up to 300 ◦C. Furthermore, the same study reported a
significant enhancement in photostability after complexation [93]. The changes in enthalpy
(∆H0) and entropy (∆S0) can also be used to confirm the spontaneous exothermic formation
of chrysin–β-CD complex. Chakraborty et al. found that the complexation of chrysin with
β-CD led to a decrease in entropy and a large negative enthalpy change, which can be
explained by the increased hydrogen bonding and van der Waals forces between chrysin
and CD, resulting in decreased rotational and translational freedom [102]. DSC analysis is
also used to assess the physical state of CD inclusion complexes. Duarte et al. used DSC to
characterise RES–Me–β-CD inclusion complexes. The DSC thermogram of unprocessed
RES powder displayed a sharp melting peak at 270 ◦C, indicating its crystalline struc-
ture. However, this endothermic peak completely disappeared upon complexing with
Me–β-CD, indicating the formation of an amorphous inclusion complex [89]. A similar
observation was reported regarding the QCT–Me–β-CD complex, where the QCT melting
endothermic peak at 300 ◦C disappeared after complexation [41]. In addition to DSC and
TGA, both proton and carbon nuclear magnetic resonance spectroscopies (H-NMR and
C-NMR respectively) are widely used to conclusively characterise CD inclusion complexes.
Significant changes in resonance frequency after complexation can indicate the formation
of the inclusion complex, the level of drug penetration in the CD cavity, and the moieties of
the drug which are inside or outside the CD’s rim [51]. Al-Rawashdeh et al. used carbon-13
NMR for the characterisation of β-CD–sunscreen agents inclusion complexes [76]. The
difference in 13C shifts between the free UV filters and the complexes helped confirm the
structures. The authors postulated that these shifts can be ascribed to a change in shielding
effects experienced once bound to CD. In addition, more specialised NMR techniques such
as NOESY, ROESY, and DOSY NMR spectroscopy have also proven useful in the charac-
terisation of CD inclusion complexes [114]. Since diffusion ordered NMR spectroscopy
(DOSY) can distinguish between compounds of differing molecular weights within the
complex mixtures, it demonstrated as particularly useful for identifying the CD inclusion
complexes. Zhao et al. used this principle to distinguish between free isoflavones, free CD,
and CD–isoflavones inclusion complexes [115].
An example of techniques used to assess the antioxidant activity is the colorimetric
assay of 2,2-diphenyl-1-picrylhydrazyl (DPPH) solutions. DPPH is a stable free radical
that forms a deep violet colour in organic solutions and undergoes discoloration once an
antioxidant is introduced into the medium [61]. This method is widely used to assess the
scavenging capacity of antioxidants, where the discoloration of DPPH solution quantitively
determines the scavenging abilities of antioxidants [100]. DPPH reagent was used to
evaluate the activity of an EGCG–γ-CD inclusion complex. It was found that the scavenged
radicals were increased by 15% after EGCG complexation with γ-CDs [61]. Using the
same method, Wei et al. assessed the scavenging ability of phloretin–HP–β-CD’s inclusion
complex, where the scavenging abilities of free and complexed phloretin were found to be
≈48% and >60%, respectively [65].
Due to their low molecular weight (usually <500 Dalton) and lipophilic structure,
natural antioxidants can permeate via the transcellular route through the epidermis layer.
While essential for good permeability, the lipophilic nature of most natural antioxidants
affects their dissolution rate and extent negatively. On the other hand, due to their high
molecular weight (>972 Da) and hydrophilic nature (i.e., negative partition coefficient),
CDs are unable to penetrate the lipophilic barrier of the skin. Instead, they adsorb at the
stratum corneum, where the encapsulated molecules are then released [116,117]. In vitro
assays are preliminary studies used to assess the antioxidants permeation through synthetic
membranes simulating human skin. However, such assays are not considered adequate on
their own to establish the activity of antioxidants. Therefore, ex vivo and in vivo assays,
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using porcine skin and volunteers, respectively, are used to evaluate the ability of the
complex to diffuse antioxidants across skin layers [118]. QCT’s skin accumulation and
percutaneous permeation were analysed ex vivo using Franz cells mounted with porcine
skin. Pure QCT was mainly accumulated in porcine skin, with no noticeable percutaneous
permeation. When a QCT–Me–β-CD complex was used, the amount of QCT retained in the
skin was slightly lower; however, a substantial amount of QCT penetrated the skin from the
complex after 24 h of application [41]. Spada et al. explored the in vitro, ex vivo, and in vivo
skin permeation of milk thistle antioxidant. Both free milk thistle and complexed HP-β-CD
were able to penetrate in vitro neither through the skin model nor ex vivo through skin
layers. In contrast, the in vivo results demonstrated that the HP–β-CD complex effectively
enhanced the skin penetration, with more than 80% of applied milk thistle penetrating
through the upper skin layer [118]. The poor correlation between ex vivo and in vivo
results was attributed to physical stress (i.e., high temperature) and the different treatment
and viability of skin used ex vivo. These results emphasise the importance of incorporating
in vivo studies to accurately assess CD’s ability to enhance drug permeation [118].
5. Conclusions
Chemical and physical UV filters are the main sunscreens’ active ingredients that
protect skin against harmful UVR. Antioxidants are usually added to sunscreens’ formu-
lation to counteract the harmful effect of UVR that was not successfully blocked by UV
filters. However, antioxidants and UV filters are prone to degradation upon exposure to
UVR and other environmental factors. This review shows that the inclusion complexes of
antioxidants and UV filters in the CDs cavity represents a promising method to enhance
sunscreens’ effectiveness and promote their stability. CDs provide a shielding cover that
enhances both antioxidants’ and UV filters’ stability upon exposure to sun and oxygen.
Furthermore, it was found that CDs could significantly enhance the aqueous solubility of
poorly soluble antioxidants, boosting their biological activities, especially as anticancer.
CDs can also control the release profile of encapsulated antioxidants and enhance their
penetration through skin layers (requiring lower doses and hence minimalised associated
risks) whilst simultaneously preventing the percutaneous permeation of UV filters.
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